Impact of age, race, and family history on COVID-19-related changes in breast cancer screening among the Boston mammography cohort study.
Naiyu ChenDavid ChengMichelle O SodipoMollie E BarnardNatalie C DuPreRulla M TamimiErica T WarnerPublished in: Breast cancer research and treatment (2023)
The rebound in screening was lower in women age ≥ 50 and lower in non-White women for diagnostic imaging. Careful attention must be paid as the COVID-19 recovery continues to ensure equitable resumption of care.
Keyphrases
- coronavirus disease
- sars cov
- polycystic ovary syndrome
- breast cancer risk
- pregnancy outcomes
- healthcare
- high resolution
- cervical cancer screening
- palliative care
- working memory
- magnetic resonance imaging
- contrast enhanced
- type diabetes
- pregnant women
- metabolic syndrome
- chronic pain
- image quality
- photodynamic therapy
- childhood cancer